Illumina, Inc.
ILMN
#751
Rank
$33.951 B
Marketcap
United States
Country
$224.84
Share price
16.59%
Change (1 day)
104.57%
Change (1 year)
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and…
Key Metrics
Trailing P/E
38.77
Forward P/E
34.11
EPS (TTM)
$5.37
Forward EPS
$6.10
Price / Book
11.08
EV / EBITDA
28.4x
Beta
1.47
Dividend Yield
—
Return on Equity
32.34%
Return on Assets
8.67%
Debt / Equity
89.04
Current Ratio
1.80
Gross Margin
67.93%
Operating Margin
21.14%
Net Profit Margin
18.34%
Free Cash Flow
$797.625M
Charts
Price history and financial performance over time.
Price & Market Cap
Aug 17 – Sep 11
+6.89%
Source: Yahoo Finance daily closes. Market cap uses the closest quarterly shares-outstanding filing for each date.
Revenue & Net Income
Annual · USD
RevenueNet Income
Latest Revenue$4.343B
Latest Net Income$850.000M
Reporting periods4
Source: Yahoo Finance annual income statements. Year is the fiscal-year end. Most recent period may be trailing-twelve-month (TTM) until the next 10-K is filed.
Compare Illumina, Inc. with competitors
Side-by-side market cap, revenue, and financial comparison.
Latest News
Latest News
ILMN
No recent news available. Set FINNHUB_API_KEY to enable news.
